Why Akso Health Group’s (AHG) Stock Is Up 5.95%
As of Wednesday, October 14, Akso Health Group’s AHG share price has surged by 5.95%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Jenna Brashear
Michael Rose
Rosalio Madrigal
| Share Statistics | AHG | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,164.0 | $1,570.8 | 48% |
|
| Shares Out (Mil) | 856.3 | 80.2 | 92% |
|
| Institutional Ownership | na | 88.7% | na |
|
| Float (Mil) | 854.0 | 58.4 | 89% |
|
| Beta | -1.00 | 0.77 | 1% |
|
| Avg Daily Volume (000s) | 5 | 655 | 14% |
|
| Price Change (52-week) |
(10.0%) | 76.0% | 42% |
|
| Growth | AHG | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.4% | na |
|
| Net Income (5yr) | 11.7% | (0.3%) | 58% |
|
| EPS (5yr) | 57.4% | 3.0% | 95 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (23.9%) | (17.5%) | 27% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AHG | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $14 | $1,505 | 10% |
|
| Net Income (TTM) (Mil) | ($19) | $30 | 24% |
|
| EPS (TTM) | ($0.026) | $0.300 | 37% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | $170 | 18% |
|
| Net Cash Flow (TTM) (Mil) | na | $7 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $416 | 0% |
|
| Enterprise Value (Q1) (Mil) | $1,253 | $2,396 | 44% |
|
| Valuation | AHG | Industry Median |
Percentile (All Stocks) |
|
| P/B | 6.47 | 2.76 | 86% |
|
| P/E | na | 26.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | AHG | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (0.1%) | 27.9% | 4% |
|
| Net Margin | (135.0%) | 1.3% | 6% |
|
| ROA | (9.2%) | 2.4% | 25% |
|
| ROE | (9.8%) | 7.4% | 27% |
|
| Liabilities to Assets | 4.6% | 61.9% | 2% |
|
| F-Score | 4 | 5 | 33% |
|
Akso Health Group did not pass any screens on 11/18/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors